lab

My work has contributed to our understanding of metabolic disease and informed treatment strategies for hyperglycemia. Current efforts focus on elucidating the glucoregulatory mechanisms of metformin and berberine–two widely used antidiabetic agents whose modes of action remain unclear. Nascent projects center around the molecular basis of fitness and seek to identify novel drug targets for type II diabetes and age-related sarcopenia. I combine various approaches from molecular biology, physiology, and functional genomics, with increasing integration of AI tools for computational tasks. In addition to research, I have mentored several high school and undergraduate students through the UChicago ResearcHStart, Northwestern CURE, and Kimberly Querrey summer internship programs.

Prior to my current position, I completed doctoral studies at Yale where I worked with Matthew Rodeheffer on adipocyte differentiation in the contexts of development and obesity. I performed undergraduate work at the Stowers Institute, University of Missouri-Kansas City, and Mayo Clinic.

A full list of my publications can be found here.

Selected Awards